These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 22555180

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Magnetic resonance imaging of cartilaginous tumors: a retrospective study of 79 patients.
    De Beuckeleer LH, De Schepper AM, Ramon F, Somville J.
    Eur J Radiol; 1995 Nov; 21(1):34-40. PubMed ID: 8654456
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cartilaginous lesions of bone.
    Unni KK.
    J Orthop Sci; 2001 Nov; 6(5):457-72. PubMed ID: 11845358
    [Abstract] [Full Text] [Related]

  • 26. Manifestations and management of osteochondromas: a retrospective analysis of 382 patients.
    Saglik Y, Altay M, Unal VS, Basarir K, Yildiz Y.
    Acta Orthop Belg; 2006 Dec; 72(6):748-55. PubMed ID: 17260614
    [Abstract] [Full Text] [Related]

  • 27. Diagnosis and prognosis of chondrosarcoma of bone.
    Rozeman LB, Hogendoorn PC, Bovée JV.
    Expert Rev Mol Diagn; 2002 Sep; 2(5):461-72. PubMed ID: 12271817
    [Abstract] [Full Text] [Related]

  • 28. [Malignant transformation in multiple cartilaginous exostoses] Diagnostic value of magnetic resonance tomography].
    Bair HJ, Schmitt R, Moos P, Fellner F, Dvorak O, Rupprecht H, Lenz M.
    Rontgenpraxis; 1997 Jul; 50(7):207-11. PubMed ID: 9324776
    [No Abstract] [Full Text] [Related]

  • 29. Is total-body MRI useful as a screening tool to rule out malignant progression in patients with multiple osteochondromas? Results in a single-center cohort of 319 adult patients.
    Van der Woude HJ, Flipsen M, Welsink C, Van der Zwan AL, Ham SJ.
    Skeletal Radiol; 2024 Jan; 53(1):141-150. PubMed ID: 37338590
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas.
    Hendel HW, Daugaard S, Kjaer A.
    Clin Nucl Med; 2002 Sep; 27(9):622-4. PubMed ID: 12192277
    [Abstract] [Full Text] [Related]

  • 35. [The value of CT and MRT in the diagnosis of cartilage-forming tumors].
    Reuther G, Mutschler W.
    Rofo; 1989 Dec; 151(6):647-52. PubMed ID: 2556737
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Chondrosarcoma is not characterized by detectable telomerase activity.
    Bovée JV, van Den Broek LJ, Cleton-Jansen AM, Hogendoorn PC.
    J Pathol; 2001 Mar; 193(3):354-60. PubMed ID: 11241416
    [Abstract] [Full Text] [Related]

  • 38. [Cartilage tumors of the skeleton].
    Jundt G, Baumhoer D.
    Pathologe; 2008 Nov; 29 Suppl 2():223-31. PubMed ID: 18820927
    [Abstract] [Full Text] [Related]

  • 39. Magnetic Resonance Imaging-Based Grading of Cartilaginous Bone Tumors: Added Value of Quantitative Texture Analysis.
    Fritz B, Müller DA, Sutter R, Wurnig MC, Wagner MW, Pfirrmann CWA, Fischer MA.
    Invest Radiol; 2018 Nov; 53(11):663-672. PubMed ID: 29863601
    [Abstract] [Full Text] [Related]

  • 40. Sarcomatous transformation in diaphyseal aclasis.
    Shah ZK, Peh WC, Wong Y, Shek TW, Davies AM.
    Australas Radiol; 2007 Apr; 51(2):110-9. PubMed ID: 17419854
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.